Australian Broker Call *Extra* Edition – Mar 12, 2026

Array
(
    [0] => Array
        (
            [0] => ((360))
            [1] => ((ALC))
            [2] => ((AMP))
            [3] => ((APE))
            [4] => ((ARB))
            [5] => ((ASG))
            [6] => ((CSL))
            [7] => ((COH))
            [8] => ((IDX))
            [9] => ((HLS))
            [10] => ((RHC))
            [11] => ((RMD))
            [12] => ((SHL))
            [13] => ((GNP))
            [14] => ((IAG))
            [15] => ((ILA))
            [16] => ((MPK))
            [17] => ((NXG))
            [18] => ((NXT))
            [19] => ((PNC))
            [20] => ((REH))
            [21] => ((SGQ))
            [22] => ((SLS))
            [23] => ((SUN))
            [24] => ((TLS))
            [25] => ((TPG))
            [26] => ((WA1))
            [27] => ((WOW))
            [28] => ((SIG))
            [29] => ((TPW))
            [30] => ((FLT))
            [31] => ((JBH))
            [32] => ((BLX))
            [33] => ((HLO))
            [34] => ((EDV))
            [35] => ((TWE))
            [36] => ((DMP))
            [37] => ((GYG))
            [38] => ((CKF))
        )

    [1] => Array
        (
            [0] => 360
            [1] => ALC
            [2] => AMP
            [3] => APE
            [4] => ARB
            [5] => ASG
            [6] => CSL
            [7] => COH
            [8] => IDX
            [9] => HLS
            [10] => RHC
            [11] => RMD
            [12] => SHL
            [13] => GNP
            [14] => IAG
            [15] => ILA
            [16] => MPK
            [17] => NXG
            [18] => NXT
            [19] => PNC
            [20] => REH
            [21] => SGQ
            [22] => SLS
            [23] => SUN
            [24] => TLS
            [25] => TPG
            [26] => WA1
            [27] => WOW
            [28] => SIG
            [29] => TPW
            [30] => FLT
            [31] => JBH
            [32] => BLX
            [33] => HLO
            [34] => EDV
            [35] => TWE
            [36] => DMP
            [37] => GYG
            [38] => CKF
        )

)

This story features LIFE360 INC, and other companies.
For more info SHARE ANALYSIS: 360
The company is included in ASX100, ASX200, ASX300, ALL-ORDS and ALL-TECH

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

360   ALC   AMP   APE   ARB   ASG   CSL   GNP   IAG   ILA   MPK   NXG   NXT   PNC   REH   SGQ   SLS   SUN   TLS   TPG   WA1   WOW  

360    LIFE360 INC

Software & Services – Overnight Price: $21.42

Canaccord Genuity rates ((360)) as Buy (1) –

Canaccord Genuity explains Life360’s fourth-quarter result showed accelerating user growth and strong revenue momentum. Total monthly active users (MAU) rose by 4.3m to 95.9m quarter-on-quarter and Paying Circles up 26% year-on-year.

Revenue increased 26% year-on-year to $146m, supported by 30% growth in subscription revenue, while earnings (EBITDA) margin reached 22.2%, slightly above the guidance range.

Canaccord points to encouraging early uptake for the new pet tracking device and growing contribution from the Nativo platform following its recent acquisition.

FY26 guidance implies to the broker 31%-39% revenue growth and around 20% user growth, with investment weighted toward the first half to support stronger second-half margins.

Buy is retained. Target is decreased to US$94 from US$115.

This report was published on March 2, 2026.

Current Price is $21.42. Target price not assessed.
Current consensus price target is $39.44, suggesting upside of 91.5%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 67.37 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 31.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 73.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 28.1.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 95.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.36.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 69.1, implying annual growth of -5.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 29.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ALC    ALCIDION GROUP LIMITED

Healthcare services – Overnight Price: $0.10

Moelis rates ((ALC)) as Initiation of coverage with Buy (1) –

Alcidion Group has executed a decade of capability expansion, international growth and product investment supporting larger, longer deployments, earning a Buy rating upon first-time coverage by Moelis. A 15c target is set.

The broker considers healthcare digitisation, interoperability demand and NHS electronic patient record contracts key growth drivers for this health technology company. 

The analyst points to FY25 improvement with positive earnings (EBITDA) and cashflow, while FY26 guidance implies consolidation or improvement, signalling increasing financial sustainability as scale builds.

Alcidion competes with large US based EPR vendors such as EPIC, Cerner (Oracle Health), Altera, and Meditech, cautions Moelis.

Competition also derives from legacy vendors controlled by Private Equity (System C, Access Rio) alongside a growing cohort of modular, workflow-focused platforms similar to its own solution.

The analyst observes additional growth potential through upselling existing clients, expanding in A&NZ and the UK, plus planned entry into Canada and the Middle East.

This report was published on March 5, 2026.

Target price is $0.15 Current Price is $0.10 Difference: $0.05
If ALC meets the Moelis target it will return approximately 50% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 100.00.

Forecast for FY27:

Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 100.00.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AMP    AMP LIMITED

Wealth Management & Investments – Overnight Price: $1.18

Jarden rates ((AMP)) as Overweight (2) –

Jarden observes the focus for AMP is increasingly turning to growth, yet after a disappointing 2025 result the stock is trading at a -19% discount to book value with the share price down -32% since the start of the year.

The broker suspects the incoming CEO is primed to restore investor confidence at the upcoming AGM in April and asserts a strategic review of the bank strategy, with timelines to reach cost of capital profitability, could be well received.

Overweight rating and $1.65 target.

This report was published on March 9, 2026.

Target price is $1.65 Current Price is $1.18 Difference: $0.47
If AMP meets the Jarden target it will return approximately 40% (excluding dividends, fees and charges).
Current consensus price target is $1.84, suggesting upside of 60.0%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 5.00 cents and EPS of 11.80 cents.
At the last closing share price the estimated dividend yield is 4.24%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.7, implying annual growth of 122.4%.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 9.8.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 6.00 cents and EPS of 11.90 cents.
At the last closing share price the estimated dividend yield is 5.08%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 12.6, implying annual growth of 7.7%.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 9.1.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

APE    EAGERS AUTOMOTIVE LIMITED

Automobiles & Components – Overnight Price: $21.16

Canaccord Genuity rates ((APE)) as Buy (1) –

February new vehicle sales fell -2.7% y/y but advanced on a sequential basis, which Canaccord Genuity puts down to seasonality factors.

Noting 2025 was a record year, the analyst expects 2026 volumes to be around 1.2m and broadly aligned with last year.

Toyota data were the reason for the weakness, but the broker remains sanguine as there are significant order backlogs, noting Toyota is a very important brand for Eagers Automotive.

China also exceeded Japan as the primary vehicle supplier to Australia as part of the switch to the suite of electric vehicle options.

Target $32 unchanged. Buy rating retained.

This report was published on March 4, 2026.

Target price is $32.00 Current Price is $21.16 Difference: $10.84
If APE meets the Canaccord Genuity target it will return approximately 51% (excluding dividends, fees and charges).
Current consensus price target is $30.43, suggesting upside of 43.6%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 120.8, implying annual growth of 38.7%.
Current consensus DPS estimate is 85.5, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 17.5.

Forecast for FY27:

Current consensus EPS estimate is 135.3, implying annual growth of 12.0%.
Current consensus DPS estimate is 91.0, implying a prospective dividend yield of 4.3%.
Current consensus EPS estimate suggests the PER is 15.7.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ARB    ARB CORPORATION LIMITED

Automobiles & Components – Overnight Price: $22.81

Canaccord Genuity rates ((ARB)) as Hold (3) –

Canaccord Genuity notes ARB Corp’s top 11 index grew 0.7% in February on the prior year, revealing some signs of stabilisation after a period of negative growth.

Ranger and LC300 saw growth, with an expectation Toyota Hilux deliveries are set to improve with new model releases.

Hold rating and $22.90 target unchanged.

This report was published on March 4, 2026.

Target price is $22.90 Current Price is $22.81 Difference: $0.09
If ARB meets the Canaccord Genuity target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $28.06, suggesting upside of 25.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 64.00 cents and EPS of 106.00 cents.
At the last closing share price the estimated dividend yield is 2.81%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.52.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 106.2, implying annual growth of -9.8%.
Current consensus DPS estimate is 71.1, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 21.0.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 66.00 cents and EPS of 110.00 cents.
At the last closing share price the estimated dividend yield is 2.89%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.2, implying annual growth of 11.3%.
Current consensus DPS estimate is 70.3, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 18.9.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ASG    AUTOSPORTS GROUP LIMITED

Automobiles & Components – Overnight Price: $2.47

Canaccord Genuity rates ((ASG)) as Buy (1) –

Autosports Group’s acquisition of Solitaire Automotive Group expands its dealership footprint into the Adelaide market, Canaccord Genuity highlights, adding operations generating around $300m in annual revenue.

The deal includes 15 vehicle and motorcycle dealerships across 10 brands, with Autosports becoming the sole retailer for several luxury marques in Adelaide.

The transaction is seen as strategically attractive, offering scale in a new market and potential margin upside from service revenue and operational efficiencies.

Forecasts are lifted modestly, with earnings per share rising slightly as the acquisition is incorporated into projections.

Canaccord raises its target to $4.84 from $4.79 and retains a Buy rating.

This report was published on March 3, 2026.

Target price is $4.84 Current Price is $2.47 Difference: $2.37
If ASG meets the Canaccord Genuity target it will return approximately 96% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 12.20 cents and EPS of 25.00 cents.
At the last closing share price the estimated dividend yield is 4.94%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.88.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 18.40 cents and EPS of 33.50 cents.
At the last closing share price the estimated dividend yield is 7.45%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.37.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CSL    CSL LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $142.58

Jarden rates ((CSL)) as Overweight (2) –

An Australian Healthcare sector review from Jarden highlights a volatile 1H26 reporting season, with guidance downgrades and ambitious second-half expectations triggering sharp market reactions.

When it comes to recoveries, the broker observes CSL, Cochlear ((COH)) and Integral Diagnostics ((IDX)) belong to a “second-half club”, while Healius ((HLS)) represents the most extreme recovery expectation across the sector.

Jarden’s analyst considers Ramsay Health Care ((RHC)) the standout performer as private health insurance pricing momentum shifts back towards hospitals, supporting revenue and margin recovery.

The analyst notes ResMed ((RMD)) remains a top pick with multi-year double-digit earnings growth, strong balance sheet and US tariff exemption, while risk surrounds Cochlear and Sonic Healthcare ((SHL)) guidance.

For CSL: $270 Target and Overweight rating.

This report was published on March 9, 2026.

Target price is $270.00 Current Price is $142.58 Difference: $127.42
If CSL meets the Jarden target it will return approximately 89% (excluding dividends, fees and charges).
Current consensus price target is $205.76, suggesting upside of 44.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 444.04 cents and EPS of 968.83 cents.
At the last closing share price the estimated dividend yield is 3.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.72.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 882.0, implying annual growth of N/A.
Current consensus DPS estimate is 436.1, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 16.2.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 459.25 cents and EPS of 1069.95 cents.
At the last closing share price the estimated dividend yield is 3.22%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 1039.3, implying annual growth of 17.8%.
Current consensus DPS estimate is 492.8, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 13.7.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

GNP    GENUSPLUS GROUP LIMITED

Infrastructure & Utilities – Overnight Price: $7.91

Moelis rates ((GNP)) as Buy (1) –

GenusPlus Group’s acquisition of Railtrain Holdings (for -$36.5m and up to -$18m in contingent earnout payments) strengthens its exposure to rail infrastructure services, Moelis notes.

Railtrain generates around $96m in revenue and $16m in earnings.

The deal supports growth across transmission, energy transition infrastructure and communications, the broker highlights, with upside risk to outer-year forecasts.

EPS forecasts across FY26-FY28 rise by 2-10% following the acquisition, reflecting stronger pipeline conversion.

Moelis retains a Buy rating and $9.49 target.

This report was published on March 5, 2026.

Target price is $9.49 Current Price is $7.91 Difference: $1.58
If GNP meets the Moelis target it will return approximately 20% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 6.50 cents and EPS of 27.10 cents.
At the last closing share price the estimated dividend yield is 0.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.19.

Forecast for FY27:

Moelis forecasts a full year FY27 dividend of 7.30 cents and EPS of 30.40 cents.
At the last closing share price the estimated dividend yield is 0.92%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.02.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

IAG    INSURANCE AUSTRALIA GROUP LIMITED

Insurance – Overnight Price: $6.88

Jarden rates ((IAG)) as Overweight (2) –

Jarden maintains Overweight ratings for domestic insurers and reiterates a preference for Insurance Australia Group versus Suncorp Group.

From a sector perspective, support is generated from a material reset of top-line market expectations and a re-acceleration of pricing in consumer lines as well as emerging stabilisation of the commercial market.

Evidence of a moderation in reinsurance rates into FY27 should provide further options for both carriers. The Insurance Australia Group target is steady at $8.10.

This report was published on March 9, 2026.

Target price is $8.10 Current Price is $6.88 Difference: $1.22
If IAG meets the Jarden target it will return approximately 18% (excluding dividends, fees and charges).
Current consensus price target is $8.45, suggesting upside of 22.8%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 44.2, implying annual growth of -23.1%.
Current consensus DPS estimate is 30.5, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 15.6.

Forecast for FY27:

Current consensus EPS estimate is 48.1, implying annual growth of 8.8%.
Current consensus DPS estimate is 33.3, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 14.3.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ILA    ISLAND PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.49

Research as a Service (RaaS) rates ((ILA)) as No Rating (-1) –

Island Pharmaceuticals has annnounced an agreement witth two strategic US-based bio-defence institutions, a trilateral agreement with the US Army medical research Institute and the Geneva Foundation.

Research as a Service (RaaS) considers this a meaningful development as it underpins the company’s stance as a known entity within the US government in the event that its lead drug Galldesivir is approved by the FDA. Valuation remains at $1.24.

Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.

This report was published on March 10, 2026.

Target price is $1.24 Current Price is $0.49 Difference: $0.75
If ILA meets the Research as a Service (RaaS) target it will return approximately 153% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.77 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 27.68.

Forecast for FY27:

Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 10.43.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

MPK    MANY PEAKS MINERALS LIMITED

Mining – Overnight Price: $0.94

Canaccord Genuity rates ((MPK)) as Speculative Buy (1) –

Many Peaks Minerals’ drilling at the Ferke Gold Project in Cote d’Ivoire continues to expand the Ouarigue prospect, Canaccord Genuity notes, with mineralisation now extending over more than 1.1km of strike.

Reverse circulation drilling confirmed a 600m northern extension, delivering multiple significant gold intercepts.

The broker notes diamond drilling around pit-constrained extensions has also returned strong results, supporting progress toward a maiden resource estimate in the June quarter.

Canaccord estimates potential for around 1.1moz at Ouarigue, with broader Ferke project potential exceeding 2.6moz.

Speculative Buy rating and target of $1.85 are maintained.

This report was published on March 3, 2026.

Target price is $1.85 Current Price is $0.94 Difference: $0.91
If MPK meets the Canaccord Genuity target it will return approximately 97% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NXG    NEXGEN ENERGY LIMITED

Uranium – Overnight Price: $18.29

Shaw and Partners rates ((NXG)) as Buy (1) –

Shaw and Partners believes the uranium market is in the early stages of a “super cycle”, expecting prices will increase to US$200/lb before returning to a long-term sustainable price of US$120/lb next decade.

NexGen Energy is one of the broker’s preferred exposures. Buy rating and $22.90 target are maintained.

The company has received its licence to construct the Rook 1 uranium project from the Canadian Nuclear Safety Commission. The company will now embark on a four-year construction process and produce first uranium early next decade.

This report was published on March 10, 2026.

Target price is $22.90 Current Price is $18.29 Difference: $4.61
If NXG meets the Shaw and Partners target it will return approximately 25% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 6.04 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 302.76.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 6.81 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 268.62.

This company reports in CAD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NXT    NEXTDC LIMITED

Cloud services – Overnight Price: $13.00

Canaccord Genuity rates ((NXT)) as Buy (1) –

Canaccord Genuity highlights a stronger forward order book for NextDC following the 1H FY26 result, supporting an accelerated ramp in contracted capacity and faster conversion to billing than previously expected.

Net revenue of $189m rose 13% y/y and underlying EBITDA of $115.3m exceeded both the estimate and consensus.

The broker notes 172MW of new contracted capacity in the half, with around 55% expected to convert to billing in FY27, earlier than market expectations.

While funding remains a key market focus, the broker believes the balance sheet remains flexible with about $4.2bn of liquidity and potential subordinated debt issuance supporting the circa -$3bn capex required to build out the current order book.

 FY28 earnings (EBITDA) forecasts are upgraded materially to reflect the faster ramp profile, although the target price is lowered to $20.40 from $22.55 due to higher capex assumptions and slightly weaker pricing expectations. Buy rating retained 

This report was published on February 27, 2026.

Target price is $20.40 Current Price is $13.00 Difference: $7.4
If NXT meets the Canaccord Genuity target it will return approximately 57% (excluding dividends, fees and charges).
Current consensus price target is $20.73, suggesting upside of 61.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 16.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 78.79.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -18.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 21.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 61.03.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -24.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PNC    PIONEER CREDIT LIMITED

Business & Consumer Credit – Overnight Price: $0.72

Shaw and Partners rates ((PNC)) as Buy (1) –

Pioneer Credit has upgraded FY26 net profit guidance to at least $23m following the repricing of its $55.5m medium term note. Shaw and Partners upgrades estimates to reflect interest savings and the gain on loan modification.

The FY27 and FY28 upgrades to EPS of 1-2% reflect more interest savings, having already assumed 200 basis points of savings.

The broker suggests the upgrade demonstrates management’s confidence it can deliver on cash collections, debt purchases and free cash flow.

Buy rating retained. Target is steady at $1.

This report was published on March 10, 2026.

Target price is $1.00 Current Price is $0.72 Difference: $0.28
If PNC meets the Shaw and Partners target it will return approximately 39% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 12.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.81.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 13.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.26.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

REH    REECE LIMITED

Furniture & Renovation – Overnight Price: $15.10

Jarden rates ((REH)) as Upgrade to Overweight from Neutral (2) –

Jarden estimates mature US stores operated at an EBIT margin of 5.4% through the first half for Reece and, with store openings expected to moderate from the second half, the first represents a “peak drag” on reported margins. Rating is upgraded to Overweight from Neutral.

The broker’s forecasts incorporate a modest volume recovery from the first half in FY27 with US EBIT margins reaching 5.7% from FY30. Target is revised up to $16.40 from $13.90 and EPS estimates are increased by 4.8% for FY26 and 3.6% for FY27.

This report was published on March 9, 2026.

Target price is $16.40 Current Price is $15.10 Difference: $1.3
If REH meets the Jarden target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $17.02, suggesting upside of 15.7%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 17.80 cents and EPS of 46.40 cents.
At the last closing share price the estimated dividend yield is 1.18%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.54.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 46.2, implying annual growth of -6.1%.
Current consensus DPS estimate is 18.3, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 31.8.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 21.50 cents and EPS of 54.70 cents.
At the last closing share price the estimated dividend yield is 1.42%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 27.61.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 55.4, implying annual growth of 19.9%.
Current consensus DPS estimate is 21.9, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 26.6.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SGQ    ST. GEORGE MINING LIMITED

Rare Earth Minerals – Overnight Price: $0.14

Canaccord Genuity rates ((SGQ)) as Speculative Buy (1) –

St George Mining’s updated Araxa Resource increases scale materially, Canaccord Genuity notes. The Mineral Resource Estimate rises to 70.9mt at 4.06% total rare earth oxides (TREO), 0.77% magnet rare earth oxides (MREO) and 0.77% niobium (Nb) 2O5.

The broker highlights the update represents a 71% increase in contained TREO and MREO and a 101% increase in niobium, supporting upcoming Scoping Study and pre feasibilty study (PFS) work.

Additional drilling results and the East Araxa discovery were excluded from the estimate, suggesting to Canaccord further growth potential ahead of a planned September quarter resource update.

Target increased to 23c from 20c. Speculative Buy rating unchanged.

This report was published on March 3, 2026.

Target price is $0.23 Current Price is $0.14 Difference: $0.09
If SGQ meets the Canaccord Genuity target it will return approximately 64% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 14.00.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 14.00.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SLS    SOLSTICE MINERALS LIMITED

Overnight Price: $0.93

Canaccord Genuity rates ((SLS)) as Speculative Buy (1) –

Canaccord Genuity notes Solstice Minerals’ Phase 1 drilling at the Nanadie copper-gold project continues to deliver strong results, highlighting potential to expand the existing 40.4mt resource.

Recent reverse circulation drilling intersected broad copper-gold mineralisation, including 106m at 0.86% copper and 0.23g/t gold outside the current resource boundary.

Additional drilling also confirmed bulk-tonnage mineralisation and high-grade zones, highlight the analysts, with holes ending in mineralisation and indicating the system remains open at depth.

Canaccord sees significant resource growth potential, with further assay results pending and a Phase 2 drilling program planned.

Speculative Buy rating and target of $1.85 are maintained.

This report was published on March 3, 2026.

Target price is $1.85 Current Price is $0.93 Difference: $0.925
If SLS meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SUN    SUNCORP GROUP LIMITED

Insurance – Overnight Price: $15.01

Jarden rates ((SUN)) as Overweight (2) –

Jarden maintains Overweight ratings for domestic insurers and reiterates a preference for Insurance Australia Group versus Suncorp Group.

From a sector perspective, support is generated from a material reset of top-line market expectations and a reacceleration of pricing in consumer lines as well as emerging stabilisation of the commercial market.

Evidence of a moderation in reinsurance rates into FY27 should provide further options for both carriers. The broker’s price target for Suncorp Group is raised to $18.80 from $18.60.

This report was published on March 9, 2026.

Target price is $18.80 Current Price is $15.01 Difference: $3.79
If SUN meets the Jarden target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $18.59, suggesting upside of 23.8%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 87.2, implying annual growth of -37.8%.
Current consensus DPS estimate is 66.5, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 17.2.

Forecast for FY27:

Current consensus EPS estimate is 117.4, implying annual growth of 34.6%.
Current consensus DPS estimate is 86.9, implying a prospective dividend yield of 5.8%.
Current consensus EPS estimate suggests the PER is 12.8.

Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TLS    TELSTRA GROUP LIMITED

Telecommunication – Overnight Price: $5.13

Jarden rates ((TLS)) as Neutral (3) –

Jarden continues to view the mobile backdrop as supportive of further earnings growth across all mobile network operators in Australia.

The analysts’ mobile market review shows $7.6bn in service revenue for the six months to December 2025, rising 4.5% year-on-year and marking a tenth consecutive half of growth.

The broker highlights around 33.7m services in operation (SIO) with SIM penetration near 120% of the population. 

Pricing is seen as the key earnings lever. It’s felt further price rises across lower-value segments are necessary to offset postpaid spin-down and shifting customer mix toward cheaper plans.

Telstra Group’s service revenue rose by 5.1% in H1, Optus  by 3.7% and TPG Telecom generated a 4.3% year-on-year increase.Prepaid average revenue per user (ARPU) growth remains strong, led by Telstra prepaid rising by 14.7% and TPG digital brands 9.4%.

Neutral rating and $4.95 target retained for Telstra.

This report was published on March 9, 2026.

Target price is $4.95 Current Price is $5.13 Difference: minus $0.18 (current price is over target).
If TLS meets the Jarden target it will return approximately minus 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $5.31, suggesting upside of 3.8%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 21.00 cents and EPS of 20.30 cents.
At the last closing share price the estimated dividend yield is 4.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.7, implying annual growth of 9.8%.
Current consensus DPS estimate is 20.8, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 24.7.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 23.00 cents and EPS of 21.30 cents.
At the last closing share price the estimated dividend yield is 4.48%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.08.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 22.1, implying annual growth of 6.8%.
Current consensus DPS estimate is 21.7, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 23.1.

Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TPG    TPG TELECOM LIMITED

Telecommunication – Overnight Price: $3.94

Jarden rates ((TPG)) as Overweight (2) –

Jarden continues to view the mobile backdrop as supportive of further earnings growth across all mobile network operators in Australia.

The analysts’ mobile market review shows $7.6bn in service revenue for the six months to December 2025, rising 4.5% year-on-year and marking a tenth consecutive half of growth.

The broker highlights around 33.7m services in operation (SIO) with SIM penetration near 120% of the population. 

Pricing is seen as the key earnings lever. It’s felt further price rises across lower-value segments are necessary to offset postpaid spin-down and shifting customer mix toward cheaper plans.

Telstra Group’s service revenue rose by 5.1% in H1, Optus  by 3.7% and TPG Telecom generated a 4.3% year-on-year increase.Prepaid average revenue per user (ARPU) growth remains strong, led by Telstra prepaid rising by 14.7% and TPG digital brands 9.4%.

Overweight rating and $3.95 target retained for TPG Telecom.

This report was published on March 9, 2026.

Target price is $3.95 Current Price is $3.94 Difference: $0.01
If TPG meets the Jarden target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $4.04, suggesting upside of 5.2%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY26:

Jarden forecasts a full year FY26 EPS of 7.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 50.51.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 9.1, implying annual growth of 31.7%.
Current consensus DPS estimate is 19.0, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 42.2.

Forecast for FY27:

Jarden forecasts a full year FY27 EPS of 10.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 36.48.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 11.2, implying annual growth of 23.1%.
Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 5.2%.
Current consensus EPS estimate suggests the PER is 34.3.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WA1    WA1 RESOURCES LIMITED

Industrial Metals – Overnight Price: $15.61

Canaccord Genuity rates ((WA1)) as Speculative Buy (1) –

WA1 Resources’ drilling at the Luni niobium (Nb) project continues to reinforce the scale and quality of the deposit, Canaccord Genuity suggests, with results broadly consistent with previous high-grade intersections.

The broker highlights recent assays from 32 holes within the 85,000m drilling campaign, targeting resource definition across eastern and western high-grade zones.

The drilling grid is designed to support conversion of mineralisation into higher-confidence resource categories ahead of an updated Mineral Resource Estimate in the June quarter.

Development activities are progressing, with further drilling planned to support metallurgical, geotechnical and resource definition workstreams, explain the analysts.

Speculative Buy rating and target of $32 maintained.

This report was published on March 3, 2026.

Target price is $32.00 Current Price is $15.61 Difference: $16.39
If WA1 meets the Canaccord Genuity target it will return approximately 105% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WOW    WOOLWORTHS GROUP LIMITED

Food, Beverages & Tobacco – Overnight Price: $35.82

Jarden rates ((WOW)) as Overweight (2) –

Jarden favours structural growers in Australian retail with market share opportunities, including the category of Defensive growth incorporating Woolworths Group, Coles Group and Sigma Healthcare ((SIG)).

It’s noted AI and Agentic commerce are driving a strategic shift in company strategies, with respect to productivity, data and transactions.

Sigma is also mentioned under Structural Growers, along with Temple & Webter ((TPW)) for its online qualities and consolidation prospects for Flight Centre Travel ((FLT)).

Tech and AI supercycle exposures like Harvey Norman ((HVN) and JB Hi-Fi ((JBH)) are also recommended.

The broker’s Market Share Winners include Temple & Webster, Beacon Lighting ((BLX)), JB Hi-Fi, Sigma (again) and Helloworld Travel ((HLO)).

As consumption structurally declines while store growth outpaces demand, quick service restaurants (QSR) and liquor appear most challenged, in the analysts’ view.

These exposures include Endeavour Group ((EDV)), Treasury Wine Estates ((TWE)), Domino’s Pizza Enterprises ((DMP)), Guzman y Gomez ((GYG)) and Collins Foods ((CKF)).

Woolworths’ Overweight rating and $35.30 target are maintained.

This report was published on March 10, 2026.

Target price is $35.30 Current Price is $35.82 Difference: minus $0.52 (current price is over target).
If WOW meets the Jarden target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $36.26, suggesting upside of 1.9%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 92.00 cents and EPS of 131.90 cents.
At the last closing share price the estimated dividend yield is 2.57%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 27.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 129.5, implying annual growth of 64.2%.
Current consensus DPS estimate is 97.5, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 27.5.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 103.00 cents and EPS of 146.70 cents.
At the last closing share price the estimated dividend yield is 2.88%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.42.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 145.7, implying annual growth of 12.5%.
Current consensus DPS estimate is 108.7, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 24.4.

Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Click to view our Glossary of Financial Terms